Pancreatic ductal adenocarcinoma

Open Access
Establishment of Patient-derived Orthotopic Xenografts (PDX) as Models for Pancreatic Ductal Adenocarcinoma
DIMITRIOS E. MAGOULIOTIS, KOSTAS LAFAZANIS, FANI KOUTSOUGIANNI, NIKOS SAKELLARIDIS, MARIA IOANNOU, DIMITRIS ZACHAROULIS and KONSTANTINOS DIMAS

In Vivo May 2022, 36 (3) 1114-1119; DOI: https://doi.org/10.21873/invivo.12809
You have access
Prognostic Impact of Coagulation Activity in Patients Undergoing Curative Resection for Pancreatic Ductal Adenocarcinoma
KAZUKI MATSUMURA, HIROMITSU HAYASHI, NORIO UEMURA, LIU ZHAO, TAKAAKI HIGASHI, TAKANOBU YAMAO, FUMIMASA KITAMURA, YUSUKE NAKAO, TOSHIHIKO YUSA, RUMI ITOYAMA, KATSUNORI IMAI, YO-ICHI YAMASHITA and HIDEO BABA

In Vivo September 2020, 34 (5) 2845-2850; DOI: https://doi.org/10.21873/invivo.12111
You have access
Clinical Implication of Pre-operative C-reactive Protein-Albumin Ratio as a Prognostic Factor of Patients With Pancreatic Ductal Adenocarcinoma: A Single-institutional Retrospective Study
MASAAKI MURAKAWA, NAOTO YAMAMOTO, YUTO KAMIOKA, MARIKO KAMIYA, SATOSHI KOBAYASHI, MAKOTO UENO, MANABU MORIMOTO, YOSUKE ATSUMI, TORU AOYAMA, HIROSHI TAMAGAWA, NORIO YUKAWA, YASUSHI RINO, MUNETAKA MASUDA and SOICHIRO MORINAGA

In Vivo January 2020, 34 (1) 347-353; DOI: https://doi.org/10.21873/invivo.11780

Main menu